These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17803222)

  • 1. Preventing cardiovascular disease in women: an update.
    Wenger NK
    Clin Cardiol; 2008 Mar; 31(3):109-13. PubMed ID: 17803222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for Primary Prevention of Coronary Heart Disease Based on Risk Stratification by the ACC/AHA Lipid Guidelines, ATP III Guidelines, Coronary Calcium Scoring, and C-Reactive Protein, and a Global Treat-All Strategy: A Comparative--Effectiveness Modeling Study.
    Galper BZ; Wang YC; Einstein AJ
    PLoS One; 2015; 10(9):e0138092. PubMed ID: 26422204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.
    Kones R
    Drug Des Devel Ther; 2011; 5():325-80. PubMed ID: 21792295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary prevention of coronary heart disease? What is cost effective in the clinical practice?].
    Kübler W
    Z Kardiol; 2005; 94 Suppl 3():III/92-9. PubMed ID: 16258799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for coronary heart disease in women.
    Hennekens CH
    Cardiol Clin; 1998 Feb; 16(1):1-8. PubMed ID: 9507775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy.
    Isles CG; Paterson JR
    QJM; 2000 Sep; 93(9):567-74. PubMed ID: 10984551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
    Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M
    Endocr Pract; 2017 Apr; 23(Suppl 2):1-87. PubMed ID: 28437620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.
    Kavousi M; Leening MJ; Nanchen D; Greenland P; Graham IM; Steyerberg EW; Ikram MA; Stricker BH; Hofman A; Franco OH
    JAMA; 2014 Apr; 311(14):1416-23. PubMed ID: 24681960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry.
    Maddox TM; Borden WB; Tang F; Virani SS; Oetgen WJ; Mullen JB; Chan PS; Casale PN; Douglas PS; Masoudi FA; Farmer SA; Rumsfeld JS
    J Am Coll Cardiol; 2014 Dec; 64(21):2183-92. PubMed ID: 25447259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults.
    Robinson JG
    Future Cardiol; 2014 Mar; 10(2):149-52. PubMed ID: 24762237
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipid management in patients at moderate risk for coronary heart disease: insights from the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).
    Gotto AM
    Am J Med; 1999 Aug; 107(2A):36S-39S. PubMed ID: 10484239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: the Copenhagen General Population Study.
    Mortensen MB; Nordestgaard BG; Afzal S; Falk E
    Eur Heart J; 2017 Feb; 38(8):586-594. PubMed ID: 28363217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs and lifestyle for the treatment and prevention of coronary artery disease: comparative analysis of the scientific basis.
    Luz PL; Nishiyama M; Chagas AC
    Braz J Med Biol Res; 2011 Oct; 44(10):973-91. PubMed ID: 21876872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in Medical Therapy and Lifestyle After Anatomical or Functional Testing for Coronary Artery Disease.
    Ladapo JA; Hoffmann U; Lee KL; Coles A; Huang M; Mark DB; Dolor RJ; Pelberg RA; Budoff M; Sigurdsson G; Severance HW; Douglas PS
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27733347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of Coronary Artery Calcium Testing Among Statin Candidates According to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).
    Nasir K; Bittencourt MS; Blaha MJ; Blankstein R; Agatson AS; Rivera JJ; Miedema MD; Sibley CT; Shaw LJ; Blumenthal RS; Budoff MJ; Krumholz HM
    J Am Coll Cardiol; 2015 Oct; 66(15):1657-68. PubMed ID: 26449135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary prevention therapies for coronary heart disease in patients with type 2 diabetes: an audit.
    Sharma KK; Guptha S; Gupta R
    J Assoc Physicians India; 2012 Apr; 60():28-30. PubMed ID: 23029739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 2013 ACC/AHA cardiovascular prevention guidelines improve alignment of statin therapy with coronary atherosclerosis as detected by coronary computed tomography angiography.
    Pursnani A; Mayrhofer T; Ferencik M; Hoffmann U
    Atherosclerosis; 2014 Nov; 237(1):314-8. PubMed ID: 25299966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Statins in secondary prevention of coronary heart disease].
    Sandhofer F
    Wien Med Wochenschr; 1999; 149(5-6):125-8. PubMed ID: 10408003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Women tolerate drug therapy for coronary artery disease as well as men do, but are treated less frequently with aspirin, beta-blockers, or statins.
    Enriquez JR; Pratap P; Zbilut JP; Calvin JE; Volgman AS
    Gend Med; 2008 Mar; 5(1):53-61. PubMed ID: 18420166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.